MLEC
Moolec Science SA·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Stock Price Surged Significantly
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MLEC
Moolec Science Sa
A leader in the use of molecular farming technology for developing food ingredients
17, Boulevard F. W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg
--
Moolec Science SA was established on 23 May 2022 under the laws of the Grand Duchy of Luxembourg. Moolec is a science-based food ingredients company focused on developing true animal proteins in plants using Molecular Farming, a disruptive, scalable, affordable and sustainable technology. Its aim is to improve the taste, nutrition and affordability of alternative protein products while building a more sustainable and equitable food system. Founded in 2020, the company is a US subsidiary of Bioceres Group, a private entity that has provided Moolec with a scientific team and certain intellectual property (Chymosin SPC and GLA patents and trademarks) since its inception. They operate in the United States, Europe and South America.
Company Financials
EPS
MLEC has released its 2025 Q1 earnings. EPS was reported at -0.07, versus the expected -0.06, missing expectations. The chart below visualizes how MLEC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MLEC has released its 2025 Q2 earnings report, with revenue of 2.64M, reflecting a YoY change of 948.32%, and net profit of -2.43M, showing a YoY change of -36.10%. The Sankey diagram below clearly presents MLEC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
